Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$135.66 - $197.02 $31,880 - $46,299
-235 Reduced 14.79%
1,354 $207,000
Q4 2022

Jan 27, 2023

BUY
$118.38 - $210.04 $188,105 - $333,753
1,589 New
1,589 $0
Q1 2022

May 02, 2022

SELL
$126.46 - $235.05 $126,586 - $235,285
-1,001 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$225.82 - $368.51 $44,034 - $71,859
-195 Reduced 16.3%
1,001 $254,000
Q3 2021

Oct 19, 2021

BUY
$221.9 - $484.47 $39,276 - $85,751
177 Added 17.37%
1,196 $460,000
Q2 2021

Jul 15, 2021

BUY
$129.91 - $234.98 $132,378 - $239,444
1,019 New
1,019 $239,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Telos Capital Management, Inc. Portfolio

Follow Telos Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.